Program Schedule

25
Defining and Reducing the Impact of Pediatric Infections

Thursday, October 9, 2014: 8:30 AM-10:00 AM
Room: The Pennsylvania Convention Center: 111-AB

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Health care workers, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Medical students and residents, Members-in-training, Microbiologists, Nurses, Pharmacists, Public health practitioners, Scientists, Vaccinologists

Tracks: Adult ID, Epidemiology and Infection Control, Global ID, Investigative ID, Pediatric ID

Moderators:  Tina Tan, MD, FIDSA, Northwestern University Feinberg School of Medicine and Mark Abzug, MD, University of Colorado School of Medicine

Presentations:
8:30 AM
77
Continued Decline in Invasive Pneumococcal Infections in Children Among 8 Children's Hospitals in the United States 2011 to 2013
Sheldon L. Kaplan, MD, FIDSA ; William J. Barson, MD ; Philana Ling Lin, MD ; Jose Romero, MD ; John S. Bradley, MD, FIDSA ; Tina Tan, MD, FIDSA ; Jill Hoffman, MD ; Laurence B. Givner, MD ; Kristina G. Hulten, PhD ; Edward Mason, PhD
8:45 AM
78
Pneumococcal Meningitis among 8 Children’s Hospitals in the United States in the 13-valent Pneumococcal Conjugate Vaccine Era
Liset Olarte, MD ; William J. Barson, MD ; Philana Ling Lin, MD ; Jose Romero, MD ; Tina Tan, MD, FIDSA ; Laurence B. Givner, MD ; John S. Bradley, MD, FIDSA ; Jill Hoffman, MD ; Kristina G. Hulten, PhD ; Edward Mason, PhD ; Sheldon L. Kaplan, MD, FIDSA
9:00 AM
79
Prevention of Antimicrobial Resistant Infection Among Children Aged <5 Years with the 13-valent Pneumococcal Conjugate Vaccine — Selected U.S. Areas, 2005–2013
Sara Tomczyk ; James Jorgensen, PhD ; Ruth Lynfield, MD ; William Schaffner, MD ; Deborah Aragon, MSPH ; Lee Harrison, MD ; Megin Nichols, DVM, MPH, DACVPM ; Susan Petit, MPH ; Ann Thomas, MD, MPH ; Arthur Reingold, MD ; Monica M. Farley, MD ; Shelley M. Zansky, PhD ; Bernard Beall, PhD ; Lesley Mcgee, PhD ; Lindsay Kim, MD, MPH
9:15 AM
80
A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates with Enterovirus Sepsis
Mark Abzug, MD ; Marian Michaels, MD ; Ellen Wald, MD ; Richard Jacobs, MD ; Jose R. Romero, MD ; Pablo J. Sanchez, MD, FIDSA ; Gregory Wilson, MD ; Paul Krogstad, MD ; Gregory Storch, MD, FIDSA ; Robert Lawrence, MD ; Mark Shelton, MD ; April Palmer, MD ; Joan Robinson, MD ; Penelope H. Dennehy, MD, FIDSA ; Sunil Sood, MD ; Gretchen Cloud, MS ; Penelope Jester, MSN BSN ; Edward Acosta, PharmD ; Richard Whitley, MD, FIDSA ; David W. Kimberlin, MD, FIDSA
9:30 AM
81
National Estimates of Pediatric Infectious Disease Hospitalizations from 1997-2009:  An Analysis of the Kids’ Inpatient Database
Chris Stockmann, MSc ; Adam L. Hersh, MD, PhD ; Kwabena Ampofo, MD ; Carrie L. Byington, MD ; Catherine Sherwin, PhD ; Michael Spigarelli, MD, PhD ; Andrew Pavia, MD, FIDSA, FSHEA
9:45 AM
82
Population-based Incidence of Childhood Pneumonia Associated with Viral Infections in a Tropical Developing Country
Fiona Havers, MD, MHS ; Alicia M. Fry, MD, MPH ; Doli Goswami, MBBS, MSc ; Kamrun Nahar, MBBS, MPH ; Amina Tahia Sharmeen, MBBS, MPH ; Mustafizur Rahman, PhD ; W. Abdullah Brooks, MD, MPH

CME Credits:

ACPE Credits:

ACPE Number:

Disclosures:

T. Tan, Merck Labs: Grant Investigator and Scientific Advisor, Research grant
Sanofi Pasteur: Consultant, Grant Investigator and Scientific Advisor, Educational grant, Research grant and Speaker honorarium
GSK: Consultant and Scientific Advisor, Consulting fee
Pfizer Wyeth: Scientific Advisor, Consulting fee
Biota: Scientific Advisor, Consulting fee

M. Abzug, None

See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, idweek.org. All Rights Reserved.

Follow IDWeek